Vol. 14. Núm. 14.
Páginas 814-821 (Junio 2024)

Protocolos de práctica asistencial
Protocolo diagnóstico y tratamiento del nódulo tiroideo

Diagnostic and treatment protocol for a thyroid nodule

E. Carrillo-LópezC. SagerM. Tapia-SanchízV. Navas-Moreno
Doi : https://10.1016/j.med.2024.07.005
Opciones
Resumen

El nódulo tiroideo consiste en el crecimiento de una lesión tiroidea que se delimita y distingue del parénquima tiroideo normal. Su incidencia está incrementándose debido al aumento de pruebas de imagen (incidentalomas tiroideos), sin que ello repercuta en una mejora en la supervivencia del cáncer de tiroides. Se ha de realizar una evaluación de la función tiroidea con medición de hormona estimulante del tiroides (TSH), comprobando así la funcionalidad del nódulo. Además, siempre se ha de efectuar una aproximación inicial de la probabilidad de malignidad mediante ecografía tiroidea que categorice cada nódulo según el Sistema Europeo de Informes e Imágenes de Tiroides (EU-TIRADS), indicando el riesgo de malignidad y, asimismo, el tamaño con el que debemos realizar una citología tiroidea (mediante punción aspiración con aguja fina). La citología nos permitirá clasificar los nódulos según las categorías Bethesda que nos aportará una estimación del riesgo de malignidad, lo cual será de suma importancia para decidir el manejo (observación frente a cirugía).

Palabras clave
Nódulo tiroideo
Ecografía tiroidea
Citología tiroidea
Abstract

A thyroid nodule consists of the growth of a thyroid lesion that is delimited and distinguished from the normal thyroid parenchyma. Its incidence is increasing due to the increase in imaging tests (incidental thyroid tumors), with no impact on thyroid cancer survival. A thyroid function test with a thyroid stimulating hormone (TSH) measurement should be performed, thus verifying nodule functionality. In addition, an initial approach should be made to the probability of malignancy via a thyroid ultrasound that categorizes each nodule according to the European Thyroid Imaging and Reporting Data System (EU-TIRADS), indicating the risk of malignancy and also the size at which a thyroid cytology (via fine-needle aspiration) should be performed. Cytology allows for classifying the nodules according to the Bethesda categories that will provide an estimate of the risk of malignancy, which will be of utmost importance when deciding on management (observation versus surgery).

Keywords
Thyroid nodule
Thyroid ultrasound
Thyroid cytology

Identifíquese

¿Aún no es suscriptor de la revista?

Comprar el acceso al artículo

Comprando el artículo el pdf del mismo podrá ser descargado

Teléfono para incidencias

De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h

Llamadas desde España 932 415 960
Llamadas desde fuera de España +34 932 415 960
Bibliografía
[1]
S. Guth
202407290444001508
202407290444001509
, U. Theune, J. Aberle, A. Galach, C.M. Bamberger.
Very high prevalence of thyroid nodules detected by high frequency (13MHz) ultrasound examination.
Eur J Clin Invest., (2009), 39 pp. 699-706
[2]
G. Grani
2024072904440015010
2024072904440015011
, M.C. Zatelli, M. Alfò, T. Montesano, M. Torlontano, S. Morelli, et al.
Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients.
Thyroid®., (2021), 31 pp. 264-271
[3]
C. Durante
2024072904440015012
2024072904440015013
, L. Hegedüs, A. Czarniecka, R. Paschke, G. Russ, F. Schmitt, et al.
2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management.
Eur Thyroid J., (2023), 12 pp. e230067
[4]
C. Durante
2024072904440015014
2024072904440015015
, L. Hegedüs, A. Czarniecka, R. Paschke, G. Russ, F. Schmitt, et al.
2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management.
Eur Thyroid J., (2023), 12 pp. e230067
[5]
B.R. Haugen
2024072904440015016
2024072904440015017
, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, et al.
2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer.
Thyroid., (2016), 26 pp. 1-133
[6]
K.K. Soelberg
2024072904440015018
2024072904440015019
, S.J. Bonnema, T.H. Brix, L. Hegedüs.
Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review.
Thyroid., (2012), 22 pp. 918-925
[7]
A.E. Jarløv
2024072904440015020
2024072904440015021
, B. Nygaard, L. Hegedüs, S.G. Hartling, J.M. Hansen.
Observer variation in the clinical and laboratory evaluation of patients with thyroid dysfunction and goiter.
Thyroid Off J Am Thyroid Assoc., (1998), 8 pp. 393-398
[8]
E. Maddaloni
2024072904440015022
2024072904440015023
, S.I. Briganti, A. Crescenzi, G. Beretta Anguissola, E. Perrella, C. Taffon, et al.
Usefulness of color doppler ultrasonography in the risk stratification of thyroid nodules.
Eur Thyroid J., (2021), 10 pp. 339-344
[9]
H.J. Moon
2024072904440015024
2024072904440015025
, J.Y. Kwak, M.J. Kim, E.J. Son, E.K. Kim.
Can vascularity at power Doppler US help predict thyroid malignancy?.
Radiology., (2010), 255 pp. 260-269
[10]
G.C.H. Yang
2024072904440015026
2024072904440015027
, K.O. Fried.
Most thyroid cancers detected by sonography lack intranodular vascularity on color doppler imaging: Review of the literature and sonographic-pathologic correlations for 698 thyroid neoplasms.
J Ultrasound Med., (2017), 36 pp. 89-94
[11]
K.Z. Swan
2024072904440015028
2024072904440015029
, V.E. Nielsen, S.J. Bonnema.
Evaluation of thyroid nodules by shear wave elastography: a review of current knowledge.
J Endocrinol Invest., (2021), 44 pp. 2043-2056
[12]
P. Trimboli
2024072904440015030
2024072904440015031
, R. Guglielmi, S. Monti, I. Misischi, F. Graziano, N. Nasrollah, et al.
Ultrasound sensitivity for thyroid malignancy is increased by real-time elastography: a prospective multicenter study.
J Clin Endocrinol Metab., (2012), 97 pp. 4524-4530
[13]
R.H.C. Filho
2024072904440015032
2024072904440015033
, F.L. Pereira, W. Iared.
Diagnostic accuracy evaluation of two-dimensional shear wave elastography in the differentiation between benign and malignant thyroid nodules: Systematic review and meta-analysis.
J Ultrasound Med., (2020), 39 pp. 1729-1741
[14]
T. Rago
2024072904440015034
2024072904440015035
, M. Scutari, V. Loiacono, F. Santini, M. Tonacchera, L. Torregrossa, et al.
Low elasticity of thyroid nodules on ultrasound elastography is correlated with malignancy, degree of fibrosis, and high expression of galectin-3 and fibronectin-1.
Thyroid., (2017), 27 pp. 103-110
[15]
A. Persichetti
2024072904440015036
2024072904440015037
, E. Di Stasio, C. Coccaro, F. Graziano, A. Bianchini, V. Di Donna, et al.
Inter- and intraobserver agreement in the assessment of thyroid nodule ultrasound features and classification systems: A blinded multicenter study.
Thyroid., (2020), 30 pp. 237-242
[16]
V.F.H. Brauer
2024072904440015038
2024072904440015039
, P. Eder, K. Miehle, T.D. Wiesner, H. Hasenclever, R. Paschke.
Interobserver variation for ultrasound determination of thyroid nodule volumes.
Thyroid., (2005), 15 pp. 1169-1175
[17]
M. Castellana
2024072904440015040
2024072904440015041
, A. Piccardo, C. Virili, L. Scappaticcio, G. Grani, C. Durante, et al.
Can ultrasound systems for risk stratification of thyroid nodules identify follicular carcinoma?.
Cancer Cytopathol., (2020), 128 pp. 250-259
[18]
F.S. Pan
2024072904440015042
2024072904440015043
, W. Wang, Y. Wang, M. Xu, J.Y. Liang, Y.L. Zheng, et al.
Sonographic features of thyroid nodules that may help distinguish clinically atypical subacute thyroiditis from thyroid malignancy.
J Ultrasound Med., (2015), 34 pp. 689-696
[19]
Y.J. Lee
2024072904440015044
2024072904440015045
, J.Y. Kim, D.G. Na, J.H. Kim, M. Oh, D.B. Kim, et al.
Malignancy risk of thyroid nodules with minimal cystic changes: a multicenter retrospective study.
Ultrason Seoul Korea., (2022), 41 pp. 670-677
[20]
G. Russ
2024072904440015046
2024072904440015047
, S.J. Bonnema, M.F. Erdogan, C. Durante, R. Ngu, L. Leenhardt.
European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS.
Eur Thyroid J., (2017), 6 pp. 225-237
[21]
L. Leenhardt
2024072904440015048
2024072904440015049
, M.F. Erdogan, L. Hegedus, S.J. Mandel, R. Paschke, T. Rago, et al.
2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer.
Eur Thyroid J., (2013), 2 pp. 147-159
[22]
L. Giovanella
2024072904440015050
2024072904440015051
, A.M. Avram, I. Iakovou, J. Kwak, S.A. Lawson, E. Lulaj, et al.
EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy.
Eur J Nucl Med Mol Imaging., (2019), 46 pp. 2514-2525
[23]
S.A. Schenke
2024072904440015052
2024072904440015053
, M.C. Kreissl, M. Grunert, A. Hach, S. Haghghi, T. Kandror, et al.
Distribution of functional status of thyroid nodules and malignancy rates of hyperfunctioning and hypofunctioning thyroid nodules in germany.
Nukl Nucl Med., (2022), 61 pp. 376-384
[24]
G. Treglia
2024072904440015054
2024072904440015055
, P. Trimboli, F.A. Verburg, M. Luster, L. Giovanella.
Prevalence of normal TSH value among patients with autonomously functioning thyroid nodule.
Eur J Clin Invest., (2015), 45 pp. 739-744
[25]
L. Hegedüs
2024072904440015056
2024072904440015057
, S.J. Bonnema.
Approach to management of the patient with primary or secondary intrathoracic goiter.
J Clin Endocrinol Metab., (2010), 95 pp. 5155-5162
[26]
E.J. de Koster
2024072904440015058
2024072904440015059
, L.F. de Geus-Oei, A.H. Brouwers, E.W.C.M. van Dam, L.T. Dijkhorst-Oei, A.C.H. van Engen-van Grunsven, et al.
[18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial.
Eur J Nucl Med Mol Imaging., (2022), 49 pp. 1970-1984
[27]
L. Hegedüs
2024072904440015060
2024072904440015061
.
The thyroid nodule.
N Engl J Med., (2004), 351 pp. 1764-1771
[28]
S.Z. Ali
2024072904440015062
2024072904440015063
, Z.W. Baloch, B. Cochand-Priollet, F.C. Schmitt, P. Vielh, P.A. VanderLaan.
The 2023 Bethesda System for reporting thyroid cytopathology.
J Am Soc Cytopathol., (2023), 12 pp. 319-325
[29]
C.C. Juhlin
2024072904440015064
2024072904440015065
, O. Mete, Z.W. Baloch.
The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading.
Endocr Relat Cancer., (2023), 30 pp. e220293
[30]
M.A. Lupo
2024072904440015066
2024072904440015067
, A.E. Walts, J.W. Sistrunk, T.J. Giordano, P.M. Sadow, N. Massoll, et al.
Multiplatform molecular test performance in indeterminate thyroid nodules.
Diagn Cytopathol., (2020), 48 pp. 1254-1264
[31]
M. Eszlinger
2024072904440015068
2024072904440015069
, K. Böhme, M. Ullmann, F. Görke, U. Siebolts, A. Neumann, et al.
Evaluation of a two-year routine application of molecular testing of thyroid fine-needle aspirations using a seven-gene panel in a primary referral setting in Germany.
Thyroid Off J Am Thyroid Assoc., (2017), 27 pp. 402-411
[32]
H.E. González
2024072904440015070
2024072904440015071
, J.R. Martínez, S. Vargas-Salas, A. Solar, L. Veliz, F. Cruz, et al.
A 10-gene classifier for indeterminate thyroid nodules: Development and multicenter accuracy study.
Thyroid Off J Am Thyroid Assoc., (2017), 27 pp. 1058-1067
[33]
K.N. Patel
2024072904440015072
2024072904440015073
, T.E. Angell, J. Babiarz, N.M. Barth, T. Blevins, Q.Y. Duh, et al.
Performance of a genomic sequencing classifier for the preoperative diagnosis of cytologically indeterminate thyroid nodules.
JAMA Surg., (2018), 153 pp. 817-824
[34]
D.L. Steward
2024072904440015074
2024072904440015075
, S.E. Carty, R.S. Sippel, S.P. Yang, J.A. Sosa, J.A. Sipos, et al.
Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: A prospective blinded multicenter study.
JAMA Oncol., (2019), 5 pp. 204-212
[35]
B. Nygaard
2024072904440015076
2024072904440015077
, L. Hegedüs, K. Gerhard Nielsen, P. Ulriksen, J.M. Hansen.
Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules.
Clin Endocrinol (Oxf)., (1999), 50 pp. 197-202
[36]
S.J. Bonnema
2024072904440015078
2024072904440015079
, L. Hegedüs.
Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome.
Endocr Rev., (2012), 33 pp. 920-980
[37]
E. Papini
2024072904440015080
2024072904440015081
, H. Monpeyssen, A. Frasoldati, L. Hegedüs.
2020 European Thyroid Association clinical practice guideline for the use of image-guided ablation in benign thyroid nodules.
Eur Thyroid J., (2020), 9 pp. 172-185
[38]
G. Mauri
2024072904440015082
2024072904440015083
, L. Hegedüs, S. Bandula, R.L. Cazzato, A. Czarniecka, O. Dudeck, et al.
European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the use of minimally invasive treatments in malignant thyroid lesions.
Eur Thyroid J., (2021), 10 pp. 185-197
[39]
S. Bernardi
2024072904440015084
2024072904440015085
, F. Giudici, R. Cesareo, G. Antonelli, M. Cavallaro, M. Deandrea, et al.
Five-year results of radiofrequency and laser ablation of benign thyroid nodules: A Multicenter Study from the Italian Minimally Invasive Treatments of the Thyroid Group.
Thyroid®., (2020), 30 pp. 1759-1770